Medicare Enrolled

Dr. John Peters, D.O.

Pulmonary Disease · Bradenton, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
2401 MANATEE AVE W, Bradenton, FL 34205
9417441336
In practice since 2005 (20 years)
NPI: 1376531103 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Peters from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Peters? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Peters

Dr. John Peters is a pulmonary disease in Bradenton, FL, with 20 years in practice. Based on federal Medicare data, Dr. Peters performed 2,046 Medicare services across 1,590 unique beneficiaries.

Between the years covered by Open Payments, Dr. Peters received a total of $68,210 from 51 pharmaceutical and/or device companies across 808 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Peters is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 31% volume in FL$ $68,210 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,046
Medicare services
Top 31% in FL for pulmonary disease
1,590
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~102 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)568$90$124
Office visit, established patient (20-29 min)410$63$88
Hospital follow-up visit, moderate complexity266$62$78
New patient office visit (45-59 min)118$123$163
Test to determine lung volumes using gas dilution or washout103$33$42
Test to examine how well the lungs exchange gases103$42$54
Hemoglobin a1c level, by device for home use101$10$10
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional101$17$22
Test to measure expiratory airflow and volume changes before and after medication administration91$28$37
Initial hospital admission, moderate complexity67$102$129
Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)56$28$28
Hospital follow-up visit, high complexity37$94$117
Test to measure expiratory airflow and volume14$19$26
Office visit, established patient, complex (40-54 min)11$127$174
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$68,210
Total received (2018-2024)
Avg $9,744/year across 7 years
Top 5% in FL for pulmonary disease
51
Companies
808
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$56,504 (82.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,706 (17.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,345
2023
$13,317
2022
$6,866
2021
$22,061
2020
$6,967
2019
$6,420
2018
$7,234

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$41,296
Boehringer Ingelheim Pharmaceuticals, Inc.
$13,259
Intuitive Surgical, Inc.
$3,194
GlaxoSmithKline, LLC.
$2,181
Actelion Pharmaceuticals US, Inc.
$2,024
Olympus Corporation of the Americas
$931
Regeneron Healthcare Solutions, Inc.
$768
Insmed, Inc.
$444
Sunovion Pharmaceuticals Inc.
$348
GENZYME CORPORATION
$328
Takeda Pharmaceuticals U.S.A., Inc.
$309
United Therapeutics Corporation
$309
Bayer HealthCare Pharmaceuticals Inc.
$247
Paratek Pharmaceuticals, Inc.
$244
Mylan Specialty L.P.
$214
Amgen Inc.
$201
Merck Sharp & Dohme LLC
$180
Electromed, Inc.
$177
Bayer Healthcare Pharmaceuticals Inc.
$163
Gilead Sciences, Inc.
$151
Shire North American Group Inc
$131
PFIZER INC.
$100
Ethicon Inc.
$92
Circassia Pharmaceuticals Inc
$75
Grifols USA, LLC
$72
Baxter Healthcare
$56
Boston Scientific Corporation
$55
Vapotherm Inc
$55
Alexion Pharmaceuticals, Inc.
$47
Genentech USA, Inc.
$47
Mallinckrodt Hospital Products Inc.
$47
Covidien LP
$39
Fisher & Paykel Healthcare Inc
$39
ABBVIE INC.
$37
JAZZ PHARMACEUTICALS INC.
$34
LivaNova USA, Inc.
$29
Masimo Corporation
$26
La Jolla Pharmaceutical Company
$25
Celgene Corporation
$22
Merck Sharp & Dohme Corporation
$21
PORTOLA PHARMACEUTICALS, INC.
$20
PORTOLA PHARMACEUTICALS, LLC
$19
Novartis Pharmaceuticals Corporation
$19
Jazz Pharmaceuticals Inc.
$19
Medtronic, Inc.
$19
Resmed Corp
$18
Allergan Inc.
$17
CSL Behring
$17
BOSTON SCIENTIFIC CORPORATION
$16
Teva Pharmaceuticals USA, Inc.
$15
Veran Medical Technologies, Inc.
$15
Top 3 companies account for 84.7% of total payments
Associated products mentioned in payments ›
ACTHAR · AIR 11 · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Abiraterone acetate · Adempas · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CINRYZE · CUVITRU · DIFICID · DUPIXENT · Da Vinci Surgical System · ELIQUIS · EMBOLD Fibered · Esbriet · FARXIGA · FASENRA · FISHER & PAYKEL HEALTHCARE · GIAPREZA · GLASSIA · General - Vascular Access · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · IMFINZI · ION · Kanuma · Kcentra · LONHALA MAGNAIR · LifeSPARC System · MONARCH · Monarch · Monarch Platform · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Olympus Bronchoscopes · Patient SafetyNet System · Precision Flow · Prolastin-C Liquid · REBLOZYL · REMODULIN · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · SuperDimension · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UPTRAVI · Utibron · VAPOTHERM · Veklury · WINREVAIR · XOLAIR · Xolair · YUPELRI · Yupelri · ZERBAXA · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for pulmonary disease in FL.

Equivalent to $3,334 per 100 Medicare services performed
Looking for a pulmonary disease in Bradenton?
Compare pulmonary diseases in the Bradenton area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
36
Per 100K population
8.7
County median income
$75,792
Nearest hospital
SUNCOAST BEHAVIORAL HEALTH CENTER
4.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Peters is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 5%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Peters experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Peters performed 568 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Peters receive payments from pharmaceutical companies?
Yes. Dr. Peters received a total of $68,210 from 51 companies across 808 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Peters's costs compare to other pulmonary diseases in Bradenton?
Dr. Peters's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Peters) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →